TIBER CREEK GROUP

Lobbying for MERCK & CO., INC · Prescription medicines, vaccines, and biologic therapies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 19, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform.

Trade (domestic/foreign)

Issues related to intellectual property protections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.